Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of Capecitabine in Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Skin

NCT01823679 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT01823679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01823679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of Capecitabine in Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Skin
Lead sponsor
Stanford University
Phase
Phase 2
Overall status
Terminated
Start date
March 31, 2013
Completion date
May 31, 2014
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent skin cancer, squamous cell carcinoma of the skin